Mitomycin C is an active pharmaceutical ingredient used in cancer chemotherapy as an alkylating agent. It has been noted by an independent committee of scientific and health experts that This compound can cause cancer.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Restricted or banned substances
Substances on this list are banned or restricted under the named regulation. This page is a compliance reference — verify your obligations under applicable law.
CAS 50-07-7
Meperidine hydrochloride
pharmaceutical raw material
Ergocalciferol
pharmaceutical raw material
(RS)-cyclophosphamide
pharmaceutical raw material
Corticosterone
pharmaceutical raw material
Mitomycin b
pharmaceutical raw material
The international HS code for Mitomycin C (CAS 50-07-7) is 2941.90.
2941.90
2941 90 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
[(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate
NWIBSHFKIJFRCO-WUDYKRTCSA-N
CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N